BAX and prostate cancer: Alshehri, M.M., et al. and Hsu, A., et al. suggested daidzein has also been investigated for its potential role in reducing the risk of breast and prostate cancer by increasing the expression of Bax in MCF-7 and PC3 prostate cancer cells [68,69].